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Carcinomas of the vulva are a relatively common gynecologic malig-
nancy of the female genital tract and represent 3–5% of all diagnosed fe-
male genital malignancies. Squamous cell carcinoma comprises 90% of
these tumors (Canavan and Cohen, 2002). Primary vulvar glandular neo-
plasms, on the other hand are rare, accounting for 1%of allmalignant neo-
plasms of the vulva. Most of them are associated with extra-mammary
Paget's disease (Doley et al., 2001). Vulvar adenocarcinomas may origi-
nate from adnexal structures, mammary-like glands, vestibular glands,
and Bartholin's glands. More common neoplasms include papillary
hidradenomas, Bartholin's carcinoma, and Paget's disease of the vulva.
Adnexal adenocarcinomas of the vulva are exceedingly rare, account-
ing for less than 0.1% of all vulvar carcinomas and as a result the literature
is limited. The diagnosis of primary vulvar adenocarcinoma remains difﬁ-
cult for pathologists and clinicians.We report a primary vulvar adenocar-
cinoma of adnexal origin and discuss the diagnosis as well as the
treatment of this unusual and uncommon neoplasm.
Clinical ﬁndings
The patientwas a 72-year-old female status-post total abdominal hys-
terectomy for ﬁbroids who presented with a suspicious lesion on the left
labiamajora. A punch biopsy of the left vulva revealed an invasive adeno-
carcinoma with angiolymphatic invasion.⁎ Corresponding author. Fax: +1 973 322 9971.
E-mail address: bstueben@barnabashealth.org (B.L. Stueben).
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The patient underwent a radical hemivulvectomy which consisted of
a 6×4×2 cm hair bearing portion of the labia majora and an adjacent
small segment of the labia minora. The center had a 1.1 cm area of ulcer-
ation. The cut surface showed an inﬁltrative tumor of the labia majora.
Microscopic examination
Microscopic sections revealed an invasive and partially mucinous
adenocarcinoma with cribriform and micropapillary features (Fig. 1A).
The neoplasmwasmorphologically reminiscent of endocervical adeno-
carcinoma and showed an inﬁltrating pattern, invading up to 9 mm in
depth. There was no evidence of extra-mammary Paget's disease.
Lymphovascular invasion was evident. Two of the ipsilateral inguinal
lymph nodes were positive for metastatic adenocarcinoma, one of
which had extracapsular extension (Fig. 1B).
Immunohistochemistry
The tumor cells were positive for cytokeratin 7 and CEA, and focally
positive for p63. The tumorwas negative forGCDFP 15, estrogen receptor,
progesterone receptor, synaptophysin, chromogranin, cytokeratin 20,
and anti-p16 (endocervical origin). Based on these ﬁndings, as well as
the history, adnexal adenocarcinoma of the vulva, apocrine type, was
diagnosed.
Discussion
Primary adenocarcinoma of the vulva majora and minora is rare, ac-
counting for 1% of vulvar neoplasms. Tumors arising from these different
locations have diagnostic implications because the vulva majora is ordi-
narily the location of sweat glands (adnexal glands), while the vulva
minora is not. Most primary adenocarcinomas of the vulva arise in
Bartholin's glands, or are associatedwith extramammary Paget's disease.
To our knowledge, there have been31 case reports in the literature of vul-
var Paget's disease associated with a primary vulvar sweat gland adeno-
carcinoma (Minagawa et al., 1995; Hou et al., 2010). Primary vulvar
sweat gland carcinomas without an associated Paget's disease are
exceedingly uncommon, with only 9 cases reported in the English lit-
erature; 5 of these were of eccrine differentiation, while 4 were of
apocrine differentiation (Hou et al., 2010). The histologic patterns of
vulvar sweat gland adenocarcinomas include ductal, acinar, papillary,
Fig. 1. A: Primary adnexal adenocarcinoma growing immediately underneath the skin
(hematoxylin and eosin, 5×). B: Lymph node totally replaced by tumor (hematoxylin
and eosin, 5×).
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syringomatous, and clear cell (Rich et al., 1981). It is difﬁcult to determine
the number of cases reported for each histologic type due to the time pe-
riod between each case as well as the unavailability of certain immuno-
histochemical stains at the time of some of the earlier reports. The rarity
and histologic variability may account for the difﬁculty that has been en-
countered in the diagnosis of vulvar sweat gland carcinomas.
There have been 38 cases of apocrine sweat gland adenocarcinomas
reported in the world literature, most commonly in the scalp, but they
also occur in the vulva majora (Chintamani et al., 2003). These tumors
have a propensity for destructive local inﬁltration aswell as spread to re-
gional lymph nodes, and have a poor prognosis overall (Alsaad et al.,
2009). In our case, the possibility of tumors present at other locations, in-
cluding sweat gland adenocarcinomas originating from other sites, was
excluded clinically. Immunohistochemically, apocrine adenocarcinomas
are usually negative for estrogen and progesterone receptors, an excep-
tion being those originating from the breast.
Vulvar adenocarcinomas of sweat gland origin have a propensity to
spread through the local lymphatics, typically to ipsilateral inguinal
lymph nodes (Alsaad et al., 2009). Several studies have looked at sur-
vival rates of apocrine adenocarcinomas in general based on metas-
tasis to inguinal nodes, with one study recommending prophylactic
lymphadenectomy, though most surgeons will only perform this
for clinically apparent lymphadenopathy (Chintamani et al., 2003).In regard to apocrine adenocarcinomas, patients without lymph
node involvement have a 56% 10-year disease-free survival rate,
which decreases to 9% if the nodes are involved (Chintamani et al.,
2003). This principal also holds true for apocrine adenocarcinomas aris-
ing from the vulva, in which lymphovascular invasion often leads to
nodal spread and widespread distant metastasis (Bagwan et al., 2009).
With respect to adenocarcinomas of the vulva, several primary
and secondary neoplasms must be considered. Two main primary le-
sions should be excluded; carcinoma of the Bartholin gland and ma-
lignant melanoma (Hou et al., 2010).
The differentiation between apocrine and eccrine adenocarci-
nomas also proves to be challenging, with no speciﬁc criteria in re-
gard to the differentiation of these two entities (Mitts et al., 1976).
However, this differentiation often makes no difference clinically be-
cause the primary treatment modality for both types is surgical exci-
sion of the vulva with margins of 1 cm or greater (Hou et al., 2010).
These tumors are radioresistant and the beneﬁt of chemotherapy is
unknown (Minagawa et al., 1995).
Carcinomas originating from Bartholin's glands may assume a
duct-forming or mucinous (adenocystic) appearance microscopically.
However, they are usually readily recognized by the examining sur-
geon because they arise in the labia minora. By contrast, primary vul-
var sweat gland carcinomas arise in the labia majora.
It is known thatmetastasis to the vulva is seenwith tumors from the
cervix, endometrium, kidney, and the urothelial tract. Since all of these
tumors may cause confusion with primary cutaneous adnexal neo-
plasms, these sights should be excluded clinically or by immunohisto-
chemistry when vulvar sweat gland carcinoma is suspected.
Conclusion
This is an extremely uncommon form of primary vulvar adenocarci-
noma, the diagnosis of which is based on morphology, immunohisto-
chemistry and clinical history as well as pattern of spread. In this case,
metastatic adenocarcinoma from the cervix, endometrium and ovary
was excluded because of the patient's history of a hysterectomy
25 years ago. In addition, the p-16 stain was negative. Paget's disease
was also not a morphologic ﬁnding. Likewise, the location of the bulk of
this neoplasm (labiamajora) aswell as the pattern of spread to the ingui-
nal lymph nodes makes Bartholin's gland carcinoma highly unlikely. The
histological ﬁndings in this case along with the pattern of spread and im-
munohistochemical ﬁndings are consistent with a primary vulvar adeno-
carcinoma of adnexal origin, a rare and possibly overlooked neoplasm.
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